MedPath

Effect of intravenous Aminophylline injection on preventing renal dysfunctio

Phase 3
Conditions
Recovery of moderate to severe asphyxia in newborns.
Asphyxia and hypoxemia
Registration Number
IRCT20181201041815N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Neonate with Moderate and Severe Asphyxia

Exclusion Criteria

Congenital Anomalies
Prematurity(Gestational age=37 week)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The neonates’ fluid intake. Timepoint: Before and after the intervention 24 hours after intervention and during the 4th and 7th day of life. Method of measurement: Using Schwartz's formula, in two studied groups.;Urine volume in the first three days,. Timepoint: Before and after the intervention 24 hours after intervention and during the 4th and 7th day of life. Method of measurement: Using Schwartz's formula, in two studied groups.;Serum electrolytes including Sodium, Potassium, Calcium, serum Creatinine. Timepoint: Before and after the intervention 24 hours after intervention and during the 4th and 7th day of life. Method of measurement: Using Schwartz's formula, in two studied groups.;GFR. Timepoint: Before and after the intervention 24 hours after intervention and during the 4th and 7th day of life. Method of measurement: Using Schwartz's formula, in two studied groups.
Secondary Outcome Measures
NameTimeMethod
ung disease. Timepoint: During the 4th and 7th day of life. Method of measurement: Chest X ray.;Intra Ventricular Hemorrhages seizure. Timepoint: During the 4th and 7th day of life. Method of measurement: Brain sonography and nursing documentation related to seizure.;Death. Timepoint: During the 4th and 7th day of life. Method of measurement: Shift documentation.
© Copyright 2025. All Rights Reserved by MedPath